What is the five-year survival rate for ovarian cancer?

The five-year survival rate of ovarian cancer is generally 30%-50%, which is specifically related to pathological stage, pathological type, treatment plan and other factors.

Five-year survival rates for ovarian cancer vary significantly by stage. The five-year survival rate of stage I ovarian cancer can reach 70%-90%. At this time, the tumor is limited to the ovary or fallopian tube, and the prognosis is better after complete surgical removal. The five-year survival rate of stage II ovarian cancer is about 50%-70%. The tumor has spread to other organs in the pelvis but is still limited to the pelvic cavity. Chemotherapy is required to control the disease. The five-year survival rate of stage III ovarian cancer drops to 20%-40%. Cancer cells have metastasized to the peritoneum or lymph nodes, and cytoreduction surgery combined with platinum-based chemotherapy is required. The five-year survival rate of stage IV ovarian cancer is less than 20%, and distant metastasis such as liver and lung involvement will significantly reduce the effectiveness of treatment. Pathological type also affects survival, with high-grade serous cancers being more aggressive, while low-grade serous or mucinous cancers progressing more slowly. Standardized treatment can improve survival rates. For example, patients who undergo satisfactory tumor reduction surgery have significantly longer survival times, and patients with platinum-sensitive recurrence can delay progression through maintenance therapy.

It is recommended to receive standardized chemotherapy and regular reexamination in a timely manner after diagnosis, maintain a balanced diet to supplement high-quality protein, exercise moderately to enhance immunity, and avoid anxiety affecting the treatment effect. People at high risk for hereditary ovarian cancer may consider genetic testing and preventive surgery.